Tag Archives: Abbot

Pharmas, Web 2.0 and regulation

For a change – ethics based regulation that differentiates between the medium and the message.

Dr. Jean Ah Kang, works at DDMAC and is in charge of Web 2.0 policy development. She speaks very well at her interview with  Mark Senak, a regulatory affairs lawyer ( eyeonfda.com ).  Here is the podcast:  FDA’s views and ideas about social media and its use in the life sciences industry.

Tell your friends and colleagues about us. Thanks!
Share this